Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 4/20 | 0.70 |
| ▸ | CCR8 | P51685 | 4/20 | 0.70 |
| ▸ | CCR5 | P51681 | 3/20 | 0.70 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.53 |
| ▸ | COPS5 | Q92905 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 2/20 | 0.38 |
| ▸ | NOS3 | P29474 | 2/20 | 0.38 |
| ▸ | NOS2 | P35228 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | GABRP | O00591 | 1/20 | 0.37 |
| ▸ | GABRD | O14764 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL182930 | 0.82 | CCR1 (1.00) | CCR1CCR8CCR5PSMD14COPS5 | |
| SCHEMBL29563986 | 0.82 | CCR1 (1.00) | CCR1CCR8CCR5PSMD14COPS5 | |
| SCHEMBL6744043 | 0.80 | CCR1 (0.95) | CCR1CCR8CCR5PSMD14COPS5 | |
| SCHEMBL30753482 | 0.80 | CCR1 (0.95) | CCR1CCR8CCR5PSMD14COPS5 | |
| SCHEMBL28568141 | 0.80 | CCR1 (0.95) | CCR1CCR8CCR5PSMD14COPS5 | |
| Water SCHEMBL23927104 | 0.80 | CCR1 (0.95) | CCR1CCR8CCR5PSMD14COPS5 | |
| SCHEMBL23777914 | 0.80 | CCR1 (0.95) | CCR1CCR8CCR5PSMD14COPS5 | |
| SCHEMBL4890980 | 0.80 | CCR1 (0.95) | CCR1CCR8CCR5PSMD14COPS5 | |
| SCHEMBL31493927 | 0.80 | CCR1 (0.95) | CCR1CCR8CCR5PSMD14COPS5 | |
| SCHEMBL30603076 | 0.80 | CCR1 (0.95) | CCR1CCR8CCR5PSMD14COPS5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11737351-B2 | Organic semiconductor material and organic photoelectric device using the same | Raynergy Tek Incorporation (TW) | 2023-08-22 | — | — | US | disclosed |
| WO-2021254493-A1 | CYCLIC COMPOUND HAVING ANTI-TUMOR ACTIVITY AND USE THEREOF | 上海翊石医药科技有限公司 | 2021-12-23 | — | — | WO | disclosed |
| US-20210230130-A1 | NON-FULLERENE ACCEPTOR COMPOUND CONTAINING BENZOSELENADIAZOLE AND ORGANIC OPTOELECTRONIC DEVICE INCLUDING THE SAME | Raynergy Tek Incorporation (TW) | 2021-07-29 | — | — | US | disclosed |
| US-20210171705-A1 | CONJUGATED POLYMER MATERIAL AND ORGANIC PHOTOVOLTAIC DEVICE USING THE SAME | Raynergy Tek Incorporation (TW) | 2021-06-10 | — | — | US | disclosed |
| US-20160351817-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11737351-B2 | Organic semiconductor material and organic photoelectric device using the same | PPOX, GJA1, GJB2 | CCR1 2822/4885CCR8 3889/4885CCR5 3558/4885 |
| US-20210230130-A1 | NON-FULLERENE ACCEPTOR COMPOUND CONTAINING BENZOSELENADIAZOLE AND ORGANIC OPTOELECTRONIC DEVICE INCLUDING THE SAME | PPOX, SQOR, RPS24 | CCR1 4582/4885CCR8 3705/4885CCR5 4475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.